# Pathway activity functions

## Single-sample pathway activity

A common question in transcriptomics is whether the genes belonging to a
given pathway are concordantly up- or down-regulated in each sample.
Several algorithms tackle this by collapsing a gene-by-sample expression
matrix into a pathway-by-sample score matrix, the most widely used being
[GSVA](https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-14-7)
and [ssGSEA](https://www.nature.com/articles/nature08460). `biverse`
provides fast versions of both with some tricks under the hood to make
them faster than the original implementations. Moreover, if you have
multiple contrasts (different drugs vs. DMSO for example). `bixverse`
also provides Rust-accelerated implementations from
[mitch](https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-020-06856-9).

``` r

library(bixverse)
```

## Data

Following the GSVA vignette convention, we generate some synthetic
expression data (Gaussian-distributed to mimic normalised microarray or
RNA-seq log counts, and Poisson-distributed to mimic raw counts)
together with a collection of random gene sets.

``` r

p <- 10000L # genes
n <- 100L # samples

# Gaussian expression matrix
X <- matrix(
  rnorm(p * n),
  nrow = p,
  dimnames = list(paste0("g", seq_len(p)), paste0("s", seq_len(n)))
)

# Poisson count matrix
X_counts <- matrix(
  rpois(p * n, lambda = 10),
  nrow = p,
  dimnames = list(paste0("g", seq_len(p)), paste0("s", seq_len(n)))
)
storage.mode(X_counts) <- "numeric"

# Random gene sets of varying size
gs <- as.list(sample(10:100, size = 250, replace = TRUE))
gs <- lapply(
  gs,
  function(n, p) paste0("g", sample(seq_len(p), size = n, replace = FALSE)),
  p
)
names(gs) <- paste0("gs", seq_along(gs))
```

## GSVA

### Gaussian kernel

The Gaussian kernel version of GSVA is appropriate for continuous
expression values (log-CPM, microarray intensities, etc.). Running it in
`bixverse` is a single call:

``` r

bixverse_res_gaussian <- calc_gsva(
  exp = X,
  pathways = gs,
  gaussian = TRUE
)

bixverse_res_gaussian[1:5, 1:5]
#>              s1          s2          s3          s4         s5
#> gs1  0.14429000 -0.05193805 -0.10172900  0.05864636  0.1887965
#> gs2  0.09091252  0.08402703  0.14600827  0.03828741  0.2023524
#> gs3  0.22356720 -0.12730249 -0.16025651  0.05151947  0.4943686
#> gs4 -0.01984082 -0.10626477 -0.06880503 -0.15200638  0.1547201
#> gs5  0.21259238 -0.00692195 -0.11410987 -0.04526692 -0.1194689
```

If the original `GSVA` Bioconductor package is available we can verify
that the results are essentially identical. Minor differences in
numerical precision arise from optimisations on the Rust side, but
per-pathway correlations between the two implementations are
consistently above 0.99.

``` r

library(GSVA)

gsvaPar <- gsvaParam(X, gs)
gsva_res_gaussian <- as.matrix(gsva(gsvaPar, verbose = FALSE))

correlations <- diag(cor(bixverse_res_gaussian, gsva_res_gaussian))

print(sprintf(
  "All pathway correlations >= 0.99: %s (min: %.4f)",
  all(correlations >= 0.99),
  min(correlations)
))
#> [1] "All pathway correlations >= 0.99: TRUE (min: 1.0000)"
```

Let’s compare speed (differences will be more pronounced, the more
computational fire power your system has.)

``` r

microbenchmark::microbenchmark(
  gsva = {
    gsvaPar <- gsvaParam(X, gs)
    gsva(gsvaPar, verbose = FALSE)
  },
  bixverse = calc_gsva(exp = X, pathways = gs, gaussian = TRUE),
  times = 3L
)
#> Unit: milliseconds
#>      expr       min        lq     mean    median        uq       max neval
#>      gsva 2498.2651 2508.4591 2520.477 2518.6531 2531.5827 2544.5123     3
#>  bixverse  569.9935  570.6981  571.000  571.4026  571.5032  571.6038     3
```

### Poisson kernel

For count data a Poisson kernel is more appropriate. The only change is
setting `gaussian = FALSE`:

``` r

bixverse_res_poisson <- calc_gsva(
  exp = X_counts,
  pathways = gs,
  gaussian = FALSE
)

bixverse_res_poisson[1:5, 1:5]
#>              s1          s2           s3          s4          s5
#> gs1  0.12639912  0.19417864 -0.044113940  0.08122935 -0.02326577
#> gs2 -0.16025598  0.15538428  0.042780417 -0.18061091  0.17353965
#> gs3  0.22191056  0.02179050  0.162914562  0.36554062 -0.50286473
#> gs4  0.09018636  0.03305160  0.231389448  0.08256497  0.19798664
#> gs5  0.07676174 -0.08870158 -0.001250495  0.13671965  0.12566044
```

And vs. the original

``` r

gsvaParPoisson <- gsvaParam(X_counts, gs, kcdf = "Poisson")
gsva_res_poisson <- as.matrix(gsva(gsvaParPoisson, verbose = FALSE))

correlations <- diag(cor(bixverse_res_poisson, gsva_res_poisson))

print(sprintf(
  "All pathway correlations >= 0.99: %s (min: %.4f)",
  all(correlations >= 0.99),
  min(correlations)
))
#> [1] "All pathway correlations >= 0.99: TRUE (min: 1.0000)"
```

And speed:

``` r

microbenchmark::microbenchmark(
  gsva = {
    gsvaPar <- gsvaParam(X_counts, gs, kcdf = "Poisson")
    gsva(gsvaPar, verbose = FALSE)
  },
  bixverse = calc_gsva(exp = X_counts, pathways = gs, gaussian = FALSE),
  times = 3L
)
#> Unit: seconds
#>      expr       min        lq      mean    median        uq       max neval
#>      gsva 18.921122 18.924511 18.925687 18.927900 18.927970 18.928039     3
#>  bixverse  2.747005  2.752807  2.756199  2.758609  2.760795  2.762981     3
```

## ssGSEA

ssGSEA, first described in [Barbie et
al.](https://www.nature.com/articles/nature08460), takes a similar
approach but does not apply a kernel-based normalisation across samples.
`bixverse` provides a Rust-optimised version here as well:

``` r

bixverse_res_ssgsea <- calc_ssgsea(
  exp = X,
  pathways = gs
)

bixverse_res_ssgsea[1:5, 1:5]
#>             s1         s2         s3         s4         s5
#> gs1 0.19201011 0.11146204 0.06954589 0.08795975 0.19183334
#> gs2 0.10545756 0.12389648 0.12675632 0.09070936 0.20519942
#> gs3 0.09642364 0.17222094 0.08236459 0.11690364 0.27537298
#> gs4 0.10914634 0.09881114 0.03566679 0.03877715 0.19311753
#> gs5 0.14132952 0.15022821 0.08974808 0.10705638 0.03486018
```

Let’s compare again against the GSVA version:

``` r

ssgseaPar <- ssgseaParam(X, gs)
ssgsea_res <- as.matrix(gsva(ssgseaPar, verbose = FALSE))

correlations <- diag(cor(bixverse_res_ssgsea, ssgsea_res))

print(sprintf(
  "All pathway correlations >= 0.99: %s (min: %.4f)",
  all(correlations >= 0.99),
  min(correlations)
))
#> [1] "All pathway correlations >= 0.99: TRUE (min: 1.0000)"
```

And check the underlying speed differences:

``` r

microbenchmark::microbenchmark(
  gsva = {
    ssgseaPar <- ssgseaParam(X, gs)
    gsva(ssgseaPar, verbose = FALSE)
  },
  bixverse = calc_ssgsea(exp = X, pathways = gs),
  times = 3L
)
#> Unit: milliseconds
#>      expr      min       lq     mean   median       uq      max neval
#>      gsva 619.2796 628.9240 637.4489 638.5684 646.5336 654.4987     3
#>  bixverse 116.4241 116.5592 116.6929 116.6944 116.8273 116.9602     3
```

## Multi-contrast enrichment (mitch)

When you have multiple contrasts - say, differential expression results
from several comparisons or different omics layers - you often want to
know which pathways show coordinated changes *across* contrasts. The
[mitch](https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-020-06856-9)
method does exactly this: it ranks genes within each contrast, computes
mean ranks per pathway, and then uses a MANOVA test to identify pathways
that are enriched in one or more contrasts simultaneously. `bixverse`
re-implements the core algorithm so that it slots into the same workflow
as the other pathway activity functions… Also, heavily multi-threaded
and designed to go **brrrrrr** in terms of speed.

`calc_mitch` expects a numeric matrix of contrast statistics (genes in
rows, contrasts in columns) and a named list of gene sets. It returns a
`data.table` containing per-pathway MANOVA p-values, FDR-adjusted
p-values, and the individual contrast-level enrichment scores and
p-values.

``` r

set.seed(42L)

contrast_data <- matrix(rnorm(3 * 26), nrow = 26)
colnames(contrast_data) <- sprintf("contrast_%i", 1:3)
rownames(contrast_data) <- letters

gene_sets <- list(
  pathway_A = sample(letters, 4),
  pathway_B = sample(letters, 5),
  pathway_C = sample(letters, 6),
  pathway_D = sample(letters, 7)
)

res <- calc_mitch(
  contrast_mat = contrast_data,
  gene_set_list = gene_sets
)

res
```

Note that pathways smaller than the internal minimum set size are
dropped from the output, and the results are sorted by significance. The
function also validates its input: passing a matrix containing `NA`
values will throw an error rather than silently producing nonsense.

### Comparison with the mitch package

When the original `mitch` package is available we can verify that the
two implementations produce identical results. Here we use the example
data bundled with `mitch`:

``` r

data(myImportedData, genesetsExample, package = "mitch")

mitch_res <- suppressMessages(mitch::mitch_calc(
  myImportedData,
  genesetsExample,
  priority = "significance",
  minsetsize = 5,
  cores = 2
))

bixverse_res <- calc_mitch(
  contrast_mat = as.matrix(myImportedData),
  gene_set_list = genesetsExample
)

# Pathway ordering and FDR values should match exactly
all(bixverse_res$pathway_names == mitch_res$enrichment_result$set) &&
  all.equal(bixverse_res$manova_fdr, mitch_res$enrichment_result$p.adjustMANOVA)
#> [1] TRUE
```

And let’s check the speed differences:

``` r

microbenchmark::microbenchmark(
  mitch = suppressMessages(mitch::mitch_calc(
    myImportedData,
    genesetsExample,
    priority = "significance",
    minsetsize = 5,
    cores = 2
  )),
  bixverse = calc_mitch(
    contrast_mat = as.matrix(myImportedData),
    gene_set_list = genesetsExample
  ),
  times = 5L
)
#> Unit: milliseconds
#>      expr        min         lq      mean     median         uq        max
#>     mitch 150.840182 152.516548 153.75373 152.896488 154.145769 158.369671
#>  bixverse   3.502307   3.546329   4.70719   3.686972   6.278439   6.521903
#>  neval
#>      5
#>      5
```

As with the GSVA and ssGSEA implementations, you should observe
meaningful speed improvements from Rust, particularly as the number of
gene sets or contrasts grows and the more cores/oomph your system has.
